跳转至内容
Merck
CN

SML0124

Sigma-Aldrich

甲磺酸雷沙吉兰 甲磺酸酯

≥98% (HPLC)

登录查看公司和协议定价

别名:
(R)-N-2-丙炔基-1-氢化茚胺甲磺酸盐 甲磺酸酯, TVP-1012, 马来酸雷沙吉兰 甲磺酸酯
经验公式(希尔记法):
C12H13N · CH4O3S
分子量:
267.34
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

质量水平

检测方案

≥98% (HPLC)

形式

powder

旋光性

[α]/D +15 to +28°, c = 0.6 mg/mL in H2O

储存条件

desiccated

颜色

white to tan

溶解性

H2O: ≥20 mg/mL

储存温度

2-8°C

SMILES字符串

CS(O)(=O)=O.C#CCN[C@@H]1CCc2ccccc12

InChI

1S/C12H13N.CH4O3S/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12;1-5(2,3)4/h1,3-6,12-13H,7-9H2;1H3,(H,2,3,4)/t12-;/m1./s1

InChI key

JDBJJCWRXSVHOQ-UTONKHPSSA-N

基因信息

human ... MAOB(4129)

应用

甲磺酸雷沙吉兰可被用于MAO B型介导的细胞信号转导研究。
甲磺酸雷沙吉兰已被用于:
  • 通过细胞凋亡调节因子Bax/Bcl-2的调节来检测其对视网膜色素变性(RP)的神经保护作用
  • 在1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的小鼠模型中用作单胺氧化酶-B抑制剂
  • 作为一种抗帕金森病药物,用于测试其对6-羟基多巴胺损伤的斑马鱼幼体运动迟缓和运动障碍样行为的拯救功能

生化/生理作用

甲磺酸雷沙吉兰是单胺氧化酶的一种不可逆抑制剂,其对B型MAO的选择性比A型高十四倍。它具有抗凋亡和神经保护活性,并已被用于治疗帕金森病。
甲磺酸雷沙吉兰是帕金森病早期的一种有效治疗选择。它可改善左旋多巴治疗患者的运动波动,并对此类患者可能是一种有用辅助手段。它具有神经保护作用并可增加多巴胺能神经元的存活。

特点和优势

该化合物是《受体分类及信号转导》手册上多巴胺和去甲肾上腺素代谢组胺合成和代谢页面上的推荐化合物。想要浏览手册的其他页面, 请单击此处

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Acute Tox. 4 Oral

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Satoka Kasai et al.
Frontiers in behavioral neuroscience, 11, 75-75 (2017-05-19)
Parkinson's disease (PD), a neurodegenerative disorder, is accompanied by various non-motor symptoms including depression and anxiety, which may precede the onset of motor symptoms. Selegiline is an irreversible monoamine oxidase-B (MAO-B) inhibitor, and is widely used in the treatment of
O Rascol et al.
Lancet (London, England), 365(9463), 947-954 (2005-03-16)
Rasagiline mesylate is a novel drug for Parkinson's disease with selective, irreversible monoamine oxidase B (MAO-B) inhibitor activity, and is effective as monotherapy in early disease. This study investigated rasagiline efficacy and safety in levodopa-treated patients with Parkinson's disease and
Dhaval R Kalaria et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 127, 204-212 (2018-02-27)
Effective treatment of Parkinson's disease (PD) involves administration of therapeutic agents with complementary mechanisms of action in order to replenish, sustain or substitute endogenous dopamine. The objective of this study was to investigate anodal co-iontophoresis of pramipexole (PRAM; dopamine agonist)
J M Rabey et al.
Clinical neuropharmacology, 23(6), 324-330 (2001-09-29)
Rasagiline mesylate (TVP-1012) is a potent, selective, non-reversible MAO-B inhibitor, without the tyramine-potentiating effect and with neuroprotective activities. The benefit of rasagiline as monotherapy in patients with early Parkinson's disease (PD) has already been reported. To evaluate the safety, tolerability
J P Finberg et al.
Neuroreport, 9(4), 703-707 (1998-04-29)
Both deprenyl and rasagiline (R(+)-N-propargyl-1-aminoindane mesylate), at a concentration of 1-10 microM, increased survival in vitro of rat E14 mesencephalic dopaminergic neurons that had been primed with 10% serum for 12 h (p < 0.05). Rasagiline, but not deprenyl, also

商品

我们公司可提供多种组胺合成和代谢相关的产品,满足您的各类研究需求。

Our company offers many products related to histamine synthesis and metabolism for your research needs.

血清素(5-羟色胺)主要存在于三种主要细胞类型中:i)中杻神经系统(CNS)和肠肌间神经丛中的血清素能神经元,ii)胃肠道粘膜中的肠嗜铬细胞,和iii)血小板。血清素的代谢主要通过外部线粒体膜酶单胺氧化酶(MAO)进行,它以两种分子亚型存在,分别称为MAO-A和MAO-B。

Serotonin is stored in cells and metabolized by MAO, influencing CNS, GI, and platelet functions.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门